Fontana et al., 2018 - Google Patents
Production of pure drug nanocrystals and nano co-crystals by confinement methodsFontana et al., 2018
View PDF- Document ID
- 1579263356856733659
- Author
- Fontana F
- Figueiredo P
- Zhang P
- Hirvonen J
- Liu D
- Santos H
- Publication year
- Publication venue
- Advanced drug delivery reviews
External Links
Snippet
The use of drug nanocrystals in the drug formulation is increasing due to the large number of poorly water-soluble drug compounds synthetized and due to the advantages brought by the nanonization process. The downsizing processes are done using a top-down approach …
- 239000003814 drug 0 title abstract description 304
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fontana et al. | Production of pure drug nanocrystals and nano co-crystals by confinement methods | |
| Thorat et al. | Liquid antisolvent precipitation and stabilization of nanoparticles of poorly water soluble drugs in aqueous suspensions: Recent developments and future perspective | |
| Goyal et al. | Nanoparticles and nanofibers for topical drug delivery | |
| Shrimal et al. | A review on novel methodologies for drug nanoparticle preparation: Microfluidic approach | |
| Singh et al. | Pullulan and pullulan derivatives as promising biomolecules for drug and gene targeting | |
| Mota et al. | Broad overview of engineering of functional nanosystems for skin delivery | |
| Xu et al. | Mesoporous systems for poorly soluble drugs | |
| BRPI0512829A (en) | preparation of pharmaceutical compositions containing nanoparticles | |
| EP4481401A3 (en) | Continuous flow microfluidic system and method | |
| WO2013132457A3 (en) | Nanocrystalline solid dispersion compositions and process of preparation thereof | |
| ES2973827T3 (en) | Process for preparing nano- or microparticles comprising a carrier polymer and one or more biologically active ingredients | |
| WO2009055693A3 (en) | Methods for forming biodegradable nanocomponents with controlled shapes and sizes via electrified jetting | |
| Moritz et al. | Mesoporous materials as elements of modern drug delivery systems for anti-inflammatory agents: A review of recent achievements | |
| Dong et al. | Clay as a matrix former for spray drying of drug nanosuspensions | |
| EP4279137A3 (en) | Oral pharmaceutical composition and method for producing particulate formulation comprising composition | |
| TR201904884T4 (en) | FORMULATIONS AND PRODUCTION METHODS OF FORMULATIONS FOR USE IN COLONIC UNLOADING | |
| EP2623058A3 (en) | Fixing device and tool for surgical holding systems | |
| EP3804704A1 (en) | Method for producing nanoparticulate rivaroxaban | |
| Abdelhamid | Nanoparticles as Pharma-ceutical Agents. MJ Anes. 1 (1): 003 | |
| WO2015011653A9 (en) | pH RESPONSIVE ORAL POLYMERIC PHARMACEUTICAL DOSAGE FORM | |
| Malm et al. | Which drugs can be used during pregnancy? | |
| ME02839B (en) | GLUCOPYRANOSYL SUBSTITUTED INDOL UREA DERIVATIVES AND THEIR USE AS SGLT INHIBITORS | |
| BR112013026352A2 (en) | solid pharmaceutical composition | |
| Dupeyrón et al. | Some applications of current organic molecules for oral drug delivery | |
| Zhao et al. | The Gibbs-free-energy landscape for the solute association in nanoconfined aqueous solutions |